Related Experiment Video
Updated: Nov 7, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
A supply chain disruption recovery strategy considering product change under COVID-19
Jingzhe Chen1, Hongfeng Wang1, Ray Y Zhong2
1College of Information Science and Engineering, Northeastern University, Shenyang, 110819, China.
Abstract:
A recent global outbreak of Corona Virus Disease 2019 (COVID-19) has led to massive supply chain disruption, resulting in difficulties for manufacturers on recovering their supply chains in a short term. This paper presents a supply chain disruption recovery strategy with the motivation of changing the original product type to cope with that. In order to maximize the total profit from product changes, a mixed integer linear programming (MILP) model is developed with combining emergency procurement on the supply side and product changes by the manufacturer as well as backorder price compensation on the demand side. The model uses a heuristic algorithm based on ILOG CPLEX toolbox. Experimental results show that the proposed disruption recovery strategy can effectively reduce the profit loss of manufacturer due to late delivery and order cancellation. It is observed that the impact of supply chain disruptions is reduced. The proposed model can offer a potentially useful tool to help the manufacturers decide on the optimal recovery strategy whenever the supply chain system experiences a sudden massive disruption.
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
Coping Strategies: Problem Focused
For example, consider a student who struggles to understand their...
Drug Product Stability
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

